StockRunway.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
New York, NY -- (SBWIRE) -- 12/05/2013 -- StockRunway.com issues special report on – CytRx Corporation(NASDAQ:CYTR), Catalyst Pharmaceutical Partners, Inc.(NASDAQ:CPRX), Golden Star Resources Ltd. (USA)(NYSEMKT:GSS) , Oxygen Biotherapeutics, Inc.(NASDAQ:OXBT)
CytRx Corporation(NASDAQ:CYTR) stock is at $2.49, up +5.51 percent from its previous close of $2.36. The stock opened the session at $2.55 and touched its highest price point at $2.70.
Stocks graphical chart shows a bullish trend during its last one month’s trading session. It remained positive with +5.96% during previous three months trade. Its recent trading volume was 2.42 million shares in comparison to its usual trading volume of 509,746.00 shares. CytRx Corporation is a biopharmaceutical research and development company specializing in oncology.
For How Long CYTR will Fight for Profitability? Read This Trend Analysis report
Catalyst Pharmaceutical Partners, Inc.(NASDAQ:CPRX) stock is at $1.97, up +5.35 percent from its previous close of $1.81.Its today’s volume is 1.81million shares in comparison to its usual trading volume of 1.52 million shares. The stock opened the session at $1.87 and touched its highest price point at $2.02.
CPRX’s quarterly performance remained green with the percentage of +14.53, while its year to date performance showed that the stock advanced overall +352.87%. Catalyst Pharmaceutical Partners, Inc. operates as development-stage specialty pharmaceutical company.
For How Long CPRX’s Gloss will Attract Investors? Find out via this report
Golden Star Resources Ltd. (USA)(NYSEMKT:GSS) experienced a upsurge of +5.07% to a market valuation of $119.78 per share for previous trading session. After opening the day at $0.45 per share, volume surged to 1,788,026.
During last one month it slipped with the percentage of -7.72. Its year to date performance remained adverse with -74.87%. Golden Star Resources Ltd. engages in the acquisition, exploration, development, and operation of gold properties.
Will GSS Continue To Move Higher? Find Out Here
Oxygen Biotherapeutics, Inc.(NASDAQ:OXBT) opened its shares at the price of $6.24 for the day, its closing price was $6.31 after gaining +4.99% for the day. The company traded with the total volume of 1,800,23 shares while its average trading aptitude remained 6.29 million shares. The company has total of 5.45 million outstanding shares and its total market capitalization is $34.36 million. Oxygen Biotherapeutics, Inc., a development stage company, engages in developing biotechnology products that deliver oxygen to target tissues in the body primarily in the United States.
Why Should Investors Buy OXBT After The Recent Gain? Just Go Here and Find Out
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you're new to penny stocks or a seasoned veteran, you'll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.
Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway's service today!
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.
Read Our Full Disclaimer at: http://www.stockrunway.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)